Adverse drug reactions related to drug-resistant tuberculosis (DR-TB) treatment in Ethiopia: Active tuberculosis drug-safety monitoring and management

Abstract

As part of the global recommendation, the national TB program and Ethiopian Food and Drug Authority have set active TB-drugs safety monitoring and management (aDSM) as an essential requirement during the introduction of new anti-TB drugs and regimens. Hence, proper implementation of aDSM is evaluated by the presence of effective monitoring, detection, management, recording, and reporting of adverse drug events of MDR-TB drugs.